Skip to main content
Fig. 6 | Biology Direct

Fig. 6

From: Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma

Fig. 6

Prognostic model response to TACE and sorafenib. (A) Expression of five DRGs in the TACE-treated GSE104580 cohort and (D) sorafenib-treated GSE109211. (B, E) Sensitivity of the 5-DRG prognostic signature to predict (B) TACE and (C) sorafenib response. (C, F) Risk values differ between (C) TACE-response and non-response groups and (F) sorafenib-response and non-response groups

Back to article page

Biology Direct

ISSN: 1745-6150

Contact us